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Oscillating hypothyroidism and hyperthyroidism 
a case-based review
WuQiang Fan, MD, Prabhat Tandon, MD and Mahesh Krishnamurthy, MD*
Internal Medicine Residency, Department of Medicine, Easton Hospital, Drexel University College
of Medicine, Easton, PA, USA
Objective/Background: To discuss a unique clinical entity where inappropriate activity of inhibitory and
stimulatory thyroid antibodies resulted in alternating hypothyroidism and hyperthyroidism.
Methods: We report the clinical history, laboratory data, and results of imaging studies, along with the
pathophysiological mechanism and the subsequent treatment in a patient with fluctuating thyroid functional
status.
Results: A 52-year-old female was treated for hypothyroidism for more than two decades. She started having
symptoms of hyperthyroidism along with a suppressed thyroid-stimulating hormone (TSH). She continued to
have persistent symptoms despite stopping her levothyroxine. Her free T3 and T4 were elevated along with an
increased radioactive uptake scan. She was diagnosedwith Graves’disease and started on methimazole, which
relieved her symptoms for a few months. Subsequently, her TSH began to rise beyond expected level, her
hypothyroid symptoms reappeared, and methimazole was discontinued. Following this, she again developed
symptoms of hyperthyroidism and thyroid values revealed an undetectable TSH. She had at least two such
documented cycles of hyperthyroidism alternating with hypothyroidism. She was eventually treated with
radioactive iodine ablation followed by levothyroxine replacement. Swinging dominance of TSH-blocking
autoantibodies (TBAb) and thyroid-stimulating autoantibodies (TSAb) triggered by methimazole and
levothyroxine, respectively, is likely the underlying mechanism.
Conclusions: Physicians should be vigilant to the phenomenon of spontaneous conversion of hypothyroidism
to hyperthyroidism, or vice versa, in a subset of patients with autoimmune thyroid disease. Repeated assess-
ment of thyroid function along with measurement of TBAb and TSAb are invaluable in identifying this rare
clinical entity.
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A
lternating hypo- and hyperthyroidism is a very
rare, yet distinct, clinical entity in that the clinical
presentation, molecular mechanism, and treat-
ment strategy are unique from common thyroid disorders
such as Graves’ disease or Hashimoto thyroiditis. Here
we report an immune-mediated case with two decades
history of hypothyroidism that spontaneously developed
hyperthyroidism, which was followed by oscillating thyroid
function between hypo- and hyperthyroidism. We discuss
recent developments of mechanistic insights and treat-
ment options for this unique disorder.
Case report
A 52-year-old female with primary hypothyroidism for
two decades was treated with levothyroxine 175 mg daily.
Over a period of 2 years, her levothyroxine dose was
reduced to 25 mg daily because of persistently suppressed
thyroid-stimulating hormone (TSH). She started to have
typical symptoms of hyperthyroidism with palpitations,
loose stools, insomnia, poor concentration, fatigue, cold
intolerance, and weight loss over a period of 3 months.
Her levothyroxine was therefore stopped but she re-
mained symptomatic.
On physical examination, her vital signs were normal;
she had intact memory, normal judgment and insight.
She had lid lag and stare and a fine resting tremor. Her
thyroid was palpable with no bruit or tenderness. The
gland measured 30 g. Her TSH was 0.21 mIU/ml (normal
0.405.00) with a free thyroxine, T4 0.77 ng/dl (normal
0.711.85), and free triiodothyronine, T3 310 pg/ml
(normal 230420). Her radioactive iodine uptake scan
revealed diffuse uptake of 54% (normal 535%) through
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immunoglobulin (TSI) was elevated at 249% (normal
B125%) and thyroglobulin was 263 ng/ml (normal 2.035).
Her symptoms were consistent with Graves’ disease and
she was started on methimazole with prompt restoration
of clinical euthyroidism and normalization of thyroid func-
tion for a few months.
Subsequently, her TSH began to rise beyond expected
level, her hypothyroid symptoms reappeared, and methi-
mazole was discontinued. Thyroid peroxidase antibody
(TPOAb) was  1,000 IU/ml. She again developed symp-
toms of hyperthyroidism and thyroid values revealed
an undetectable TSH. At this point, she was placed
on propylthiouracil 25 mg daily. Four months later her
TSH increased and her propylthiouracil was stopped.
Her levothyroxine was restarted.
She had documented cycles of hypothyroidism alter-
nating with hyperthyroidism. A complete evaluation of
the hypothalamic-pituitary axis was done which was
unremarkable.
She again started having symptoms of hyperthyroi-
dism a third time after restarting levothyroxine and
was finally treated with thyroid ablation with 12 mCi
of radioactive iodine. Figure 1 depicts her fluctuating
FT4 and TSH.
Discussion
There are two types of thyrotropin receptor (TSHR)
autoantibodies found in immune disorders of the thyroid,
namely thyroid-stimulating autoantibodies (TSAb) and
TSH-blocking autoantibodies (TBAb). TSAb, by activat-
ing TSHR, is the direct cause of Graves’ disease. In con-
trast, TBAb very rarely causes hypothyroidism by blocking
endogenous TSH (1).
Takeda et al. (2) noticed that both types of TSHR
antibodies can coexist in one patient, and the patient’s
thyroid function may change depending on the alteration
in balance between these two types of antibodies. This
will lead to a remarkable clinical phenomenon, where a
patient can evolve from TBAb-induced hypothyroidism
to TSAb-induced hyperthyroidism, or vice versa.
Recent studies on these two antibodies have addition-
ally concluded that switching between TBAb and TSAb
(or vice versa) occurs in rare patients after levothyroxine
for hypothyroidism or anti-thyroid drug treatment for
Graves’ disease (3). These changes include differences
in TSAb versus TBAb concentrations, affinities, and/or
potencies. Namely, anti-thyroid drugs reduce initially low
TSAb levels even further, leading to TBAb dominance;
whereas, TSAb emergence after levothyroxine treatment
may be sufficient to counteract TBAb inhibition, and
trigger hyperthyroidism.
Fig. 1. Fluctuating free T4 and TSH values over time.
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roidism and achieved euthyroid status following treatment
with levothyroxine. This quiescent status was disrupted
two decades later when she developed hyperthyroidism.
The etiology for her hypothyroidism was thought to be
Hashimoto’s thyroiditis (HT), which is usually an irre-
versible condition where massive lymphocytic infiltra-
tion and fibrosis destroy the hormone producing tissue,
resulting in lifelong thyroid failure. An alternative explana-
tion is that she had TBAb-induced hypothyroidism,
which is distinct from HT, yet can have high TPOAb
and thyroglobulin antibody (TgAb) (3). Important dis-
tinguishing clinical features of TBAb induced hypo-
thyroidism as compared to HT includes thyroid atrophy
presenting at onset of clinical disease. HT can have
thyroid atrophy, but usually at advanced stage. Our
patient’s characteristic clinical course of oscillating
thyroid function status in response to levothyroxine and
methimazole/propylthiouracil is highly suggestive that
she has underlying alternating TBAb and TSAb.
The occurrence of ‘oscillating’ emphasizes the need for
careful patient monitoring and special management.
Adding levothyroxine along with methimazole could
be an option, but close titration of individual drugs is
essential to achieve euthyroidism, which requires frequent
office visits and blood draws with added worries, expense,
and inconvenience. Radioactive iodine (I-131) ablation
followed by levothyroxine became the obvious choice
to achieve a more permanent definitive solution. Of
note, an alternating hypo- and hyperthyroidism are more
commonly associated with ophthalmopathy (4). In patients
with prominent eye symptoms, thyroidectomy may be con-
sidered given that radio-iodine is associated with wors-
ening of ophthalmopathy. Management of children with
autoimmune alternating hypo- and hyperthyroidism is
challenging both from a medical and familial perspective.
I-131 ablation can be considered in older children ( 10
years). Younger children usually need surgery (5).
Conclusions
Physicians should be vigilant to the phenomenon of spon-
taneous conversion of hypothyroidism to hyperthyroidism,
or vice versa, in a subset of patients with autoimmune
thyroid disease.The thyroid function at thetime ofpresen-
tation should not be assumed as constant. Repeated
assessment of thyroid function in patients with clinical
symptomsofthyroiddysfunctionalongwithmeasurement
of TBAb and TSAb are invaluable in identifying this
rare clinical entity of oscillating hypothyroidism and
hyperthyroidism and initiating appropriate therapy.
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